Reducing Hereditary Cancer Act of 2022
Summary
Reducing Hereditary Cancer Act of 2022 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2022
Committee Review
Floor Vote
President
Introduced Feb 16, 2022
Last action Feb 16, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Feb 16, 2022
Committee
Read twice and referred to the Committee on Finance.
upper
Feb 16, 2022
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Lisa Murkowski
RRepublican
Co
Angus S. King, Jr.
IIndependent
Co
Benjamin L. Cardin
DDemocratic
Co
Chris Van Hollen
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 3656
Scope: US
Hi! I can help you understand S 3656. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline